JTM

official impact factor 3.51

Open Access

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

Mads H Andersen*, Rikke B Soerensen, Jürgen C Becker and Per thor Straten

Journal of Translational Medicine 2006, 4:38 doi:10.1186/1479-5876-4-38

Accesses  

  • Last 30 days: 41 accesses
  • Last 365 days: 461 accesses
  • All time: 2700 accesses

Cited by